Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
Authors:
- Veronica MollicaVMVeronica Mollica
- Vincenzo Di NunnoVNVincenzo Di Nunno
- Alessia CimadamoreAlessia Cimadamore
- Antonio Lopez-BeltranAntonio Lopez-Beltran
- Liang ChengLiang Cheng
- Matteo SantoniMSMatteo Santoni
- Marina ScarpelliMSMarina Scarpelli
- Rodolfo MontironiRMRodolfo Montironi
- Francesco MassariFrancesco Massari
Open Access
Abstract
Management of metastatic or advanced prostate cancer has acquired several therapeutic approaches that have drastically changed the course of the disease. In particular due to the high sensitivity of prostate cancer cells to hormone depletion, several agents able to inhibit hormone production or binding to nuclear receptor have been evaluated and adopted in clinical practice. However, despite several hormonal treatments being available nowadays for the management of advanced or metastatic prostate cancer, the natural history of the disease leads inexorably to the development of resistance to hormone inhibition. Findings regarding the mechanisms that drive this process are of particular and increasing interest as these are potentially related to the identification of new targetable pathways and to the development of new drugs able to improve our patients’ clinical outcomes.Keywords
This publication has 79 references indexed in Scilit:
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer GrowthCancer Cell, 2011
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Systematic Structure-Function Analysis of Androgen Receptor Leu701 Mutants Explains the Properties of the Prostate Cancer Mutant L701HJournal of Biological Chemistry, 2010
- Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate CancerCancer Investigation, 2009
- Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylationGenes & Development, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Locus-Wide Chromatin Remodeling and Enhanced Androgen Receptor-Mediated Transcription in Recurrent Prostate Tumor CellsMolecular and Cellular Biology, 2006